CoChat

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

Open access
Zádori, Dénes, Klivényi, Péter, Plangár, Imola, Toldi, József, Vécsei, László · 2011 · Journal of Cellular and Molecular Medicine
Cited by 66

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

• Introduction • The role of mitochondrial impairment and oxidative stress in neurodegeneration - Background - Parkinson’s disease - Huntington’s disease • Glutamate excitotoxicity in neurodegeneration - Background - Parkinson’s disease - Huntington’s disease • The kynurenine pathway - Historical overview - The biosynthesis of neuroactive kynurenines - Neuroactive kynurenines: sites of action • Neuroactive kynurenines in neurodegenerative disorders - Parkinson’s disease - Huntington’s disease • Endogenous neuroprotection in Parkinson’s and Huntington’s diseases - Background - L-carnitine - L-carnosine - Coenzyme Q10 - Creatine - Cysteamine/cystamine - Eicosapentaenoic acid - α-lipoic acid - Pyruvate - Taurine - Tocopherol - L-KYN/KYNA • Concluding remarks Parkinson’s disease (PD) and Huntington’s disease (HD) are progressive chronic neurodegenerative disorders that are accompanied by a considerable impairment of the motor functions. PD may develop for familial or sporadic reasons, whereas HD is based on a definite genetic mutation. Nevertheless, the pathological processes involve oxidative stress and glutamate excitotoxicity in both cases. A number of metabolic routes are affected in these disorders. The decrease in antioxidant capacity and alterations in the kynurenine pathway, the main pathway of the tryptophan metabolism, are features that deserve particular interest, because the changes in levels of neuroactive kynurenine pathway compounds appear to be strongly related to the oxidative stress and glutamate excitotoxicity involved in the disease pathogenesis. Increase of the antioxidant capacity and pharmacological manipulation of the kynurenine pathway are therefore promising therapeutic targets in these devastating disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2010.01237.x

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 66

Metadata

Authors
Zádori, D., Klivényi, P., Plangár, I., Toldi, J., & Vécsei, L.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2011-04
Volume
15
Issue
4
Pages
701-717
ISSN
1582-1838 (ISSN-L)
OpenAlex
W2069370488
Cited by
66
References
30
FWCI
1.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines. https://app.cochat.ai/papers/10.1111/j.1582-4934.2010.01237.x
The paper
Zádori, D., Klivényi, P., Plangár, I., Toldi, J., & Vécsei, L. (2011). Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2010.01237.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.